Drug intelligence / Profile preview

MaxGXL

Development stage
Unknown
Lead developer
Max International
Modality
Small Molecules
Administration
Oral
01

Overview

MaxGXL, originally marketed as Connexion GXL, is a dietary supplement formulated to enhance the body's endogenous production of glutathione, a vital intracellular antioxidant. Developed by Dr. Robert Keller and marketed by Max International, the product provides a proprietary blend of glutathione precursors, including N-acetyl cysteine (NAC) and L-glutamine, which are rate-limiting components in the synthesis of glutathione. The formulation also includes alpha-lipoic acid to support the recycling of glutathione and other antioxidants, as well as quercetin and cordyceps for additional metabolic and immune support. MaxGXL is primarily indicated for reducing oxidative stress, supporting immune function, and promoting overall cellular health by maintaining optimal glutathione levels, which typically decline with age and environmental stressors.

Brand names
MaxGXLConnexion GXL
Other names
GXLGlutathione Accelerator
02

Targets

GCL (Gamma-glutamylcysteine Synthetase)

Beyond the preview

Go deeper on MaxGXL.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MaxGXL.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call